Clinical Trial Update: Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports on the immunogenicity and safety of group A and C meningococcal polysaccharide conjugate vaccine in healthy infants aged 3-5 mont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Group A and C meningococcal polysaccharide conjugate vaccine

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Healthy Population | Phase 3 | Status: UNKNOWN